NCT06010485

Brief Summary

Children who continue to walk on their tiptoes after developing a heel-toe gait normally are diagnosed with idiopathic toe walking (ITW). The study's aim was to investigate the effects of serial casting and physical therapy on joint range of motion (ROM), toe walking severity, functional health and health-related quality of life, walking balance, and satisfaction from treatment in ITW, in comparison with the control group.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 24, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2024

Completed
Last Updated

August 24, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

August 21, 2023

Last Update Submit

August 23, 2023

Conditions

Keywords

Idiopathic Toe WalkingSerial CastingExercise

Outcome Measures

Primary Outcomes (15)

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with extended knee

    Day 0

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with extended knee

    3rd week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with extended knee

    7th week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with extended knee

    15th week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with extended knee

    27th week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with flexed knee

    Day 0

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with flexed knee

    3rd week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with flexed knee

    7th week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with flexed knee

    15th week

  • Range of Motion (ROM)

    Ankle dorsiflexion ROM with flexed knee

    27th week

  • Toe Walking Severity Scale

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows. Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait \<10%) Stage 6: Normal heel strike

    Day 0

  • Toe Walking Severity Scale

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows. Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait \<10%) Stage 6: Normal heel strike

    3rd week

  • Toe Walking Severity Scale

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows. Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait \<10%) Stage 6: Normal heel strike

    7th week

  • Toe Walking Severity Scale

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows. Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait \<10%) Stage 6: Normal heel strike

    15th week

  • Toe Walking Severity Scale

    The family is asked how long the child tiptoe walks during the day. The evaluation is as follows. Stage 1: Toe walking 76-100% of the time Stage 2: Toe walking 51-75% of the time Stage 3: Toe walking 26-50% of the time Stage 4: Toe walking 10-25% of the time Stage 5: Sole pressing but early heel lift (occasional toe gait \<10%) Stage 6: Normal heel strike

    27th week

Secondary Outcomes (14)

  • Pediatric Outcomes Data Collection Instrument (PODCI)

    Day 0

  • Pediatric Outcomes Data Collection Instrument (PODCI)

    3rd week

  • Pediatric Outcomes Data Collection Instrument (PODCI)

    7th week

  • Pediatric Outcomes Data Collection Instrument (PODCI)

    15th week

  • Pediatric Outcomes Data Collection Instrument (PODCI)

    27th week

  • +9 more secondary outcomes

Study Arms (3)

Serial Casting

ACTIVE COMPARATOR

The serial casting group received intermittent serial casting once every three days for three weeks.

Other: Serial Casting

Exercise

ACTIVE COMPARATOR

The physical therapy group underwent three sessions per week for three weeks, consisting of stretching exercises, strengthening exercises, balance training, proprioception exercises, and walking on heels.

Other: Exercise

Control Group

NO INTERVENTION

This group consists of the patients on the waitlist.

Interventions

A short leg cast is applied to the serial casting group by an orthopedic specialist once every three days for three weeks.

Serial Casting

Stretching exercises, strengthening exercises, balance exercises, proprioception exercises, and heel walking exercises are applied to the physical therapy group for 3 weeks with a physiotherapist for 3 sessions a week.

Exercise

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Aged 3-10 years
  • Patients with idiopathic toe walking diagnosis
  • To be evaluated by a pediatric neurologist, not to have abnormal findings in cranial and all spinal magnetic resonance imaging and electrophysiological examinations performed when deemed necessary, and creatinine kinase values are within normal limits ((Absence of any neurological, orthopedic or psychiatric pathology to explain the toe walking pattern (cerebral palsy, neuropathy, myopathy, autism, developmental disorders, etc.)

You may not qualify if:

  • Have previously conservative or surgical treatment
  • Presence of plantar flexion contracture

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fatih Sultan Mehmet Trainig and Research Hospital

Istanbul, 34752, Turkey (Türkiye)

Location

Related Publications (8)

  • Pomarino D, Ramirez Llamas J, Martin S, Pomarino A. Literature Review of Idiopathic Toe Walking: Etiology, Prevalence, Classification, and Treatment. Foot Ankle Spec. 2017 Aug;10(4):337-342. doi: 10.1177/1938640016687370. Epub 2017 Jan 16.

    PMID: 28092971BACKGROUND
  • Engelbert R, Gorter JW, Uiterwaal C, van de Putte E, Helders P. Idiopathic toe-walking in children, adolescents and young adults: a matter of local or generalised stiffness? BMC Musculoskelet Disord. 2011 Mar 21;12:61. doi: 10.1186/1471-2474-12-61.

    PMID: 21418634BACKGROUND
  • Herrin K, Geil M. A comparison of orthoses in the treatment of idiopathic toe walking: A randomized controlled trial. Prosthet Orthot Int. 2016 Apr;40(2):262-9. doi: 10.1177/0309364614564023. Epub 2015 Jan 27.

    PMID: 25628380BACKGROUND
  • Pomarino D, Ramirez Llamas J, Pomarino A. Idiopathic Toe Walking: Family Predisposition and Gender Distribution. Foot Ankle Spec. 2016 Oct;9(5):417-22. doi: 10.1177/1938640016656780. Epub 2016 Jul 1.

    PMID: 27370652BACKGROUND
  • Satila H, Beilmann A, Olsen P, Helander H, Eskelinen M, Huhtala H. Does Botulinum Toxin A Treatment Enhance the Walking Pattern in Idiopathic Toe-Walking? Neuropediatrics. 2016 Jun;47(3):162-8. doi: 10.1055/s-0036-1582138. Epub 2016 Apr 18.

    PMID: 27089542BACKGROUND
  • Engstrom P, Bartonek A, Tedroff K, Orefelt C, Haglund-Akerlind Y, Gutierrez-Farewik EM. Botulinum toxin A does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial. J Bone Joint Surg Am. 2013 Mar 6;95(5):400-7. doi: 10.2106/JBJS.L.00889.

    PMID: 23467862BACKGROUND
  • Williams CM, Tinley P, Curtin M. The Toe Walking Tool: a novel method for assessing idiopathic toe walking children. Gait Posture. 2010 Oct;32(4):508-11. doi: 10.1016/j.gaitpost.2010.07.011. Epub 2010 Aug 7.

    PMID: 20692159BACKGROUND
  • Giray E, Akpinar P, Illeez OG, Kahraman HC, Kocibar M, Kutsal A, Hacifazlioglu NE, Uyur E, Unlu Ozkan F, Aktas I, Yilmaz B, Karadag-Saygi E. A comparative randomized-controlled trial of serial casting and exercises on ankle range of motion, toe walking severity, walking balance, and functional health-related quality of life in children with idiopathic toe walking. J Pediatr Orthop B. 2025 Sep 1;34(5):465-476. doi: 10.1097/BPB.0000000000001250. Epub 2025 Jul 29.

MeSH Terms

Conditions

Motor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Esra Giray

    Fatih Sultan Mehmet training and Research Hospital, Istanbul-Turkey

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized, single blinded, controlled study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2023

First Posted

August 24, 2023

Study Start

September 1, 2023

Primary Completion

March 1, 2024

Study Completion

April 15, 2024

Last Updated

August 24, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations